Ibuflam (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase enzymes COX‑1 and COX‑2. This inhibition prevents the conversion of arachidonic acid into prostaglandins, which are key mediators of pain, fever, and inflammation. Lower prostaglandin levels result in decreased sensitisation of pain receptors and reduced inflammatory responses.

The appropriate dose of Ibuflam is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Dosage may vary from a single low dose for occasional pain to multiple doses per day for chronic conditions, and it should always follow the prescriber’s instructions.

Ibuprofen is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular function. In earlier trimesters, use should only occur if clearly needed and prescribed by a qualified practitioner. Limited data exist for breastfeeding, and the drug may pass into milk; therefore, a healthcare professional should evaluate the risk‑benefit ratio.

To order Ibuflam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Ibuflam (ibuprofen) shares the core NSAID properties of analgesia, antipyresis, and anti‑inflammation with agents such as naproxen and diclofenac. Compared with some NSAIDs, ibuprofen has a relatively short half‑life, which may allow flexible dosing but can require multiple daily administrations for sustained effect. Its safety profile is similar, though individual tolerability varies.

Ibuflam should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments. No special refrigeration is required for this oral formulation.

Ibuflam is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The tablet (or other oral form) should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, especially in patients with a history of ulcers or who use anticoagulants; renal impairment, which may manifest as reduced urine output or swelling; and cardiovascular events such as heart attack or stroke, particularly with high‑dose or prolonged therapy. Any signs of severe allergic reaction, such as swelling of the face or difficulty breathing, require immediate medical attention.

Ibuflam should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe heart failure, uncontrolled hypertension, or significant renal impairment. It is also contraindicated in the third trimester of pregnancy and in patients taking certain anticoagulants or selective COX‑2 inhibitors without medical supervision.